Senisca

Description: Senisca develops oligonucleotide-based therapies to reverse cellular senescence, targeting aging-related diseases using patented gene expression tech.

Country: UK

Based in: Exeter

Founded: 2020

Funding Stage: Pre-Seed

Tags: ['Biotechnology', 'Health Care', 'Medical Device']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.